NAUREX
Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR). Using these discoveries, Naurex researchers have generated novel chemical drug classes known as glycine-site functional partial agonists (GFPAs), which modulate the receptor in a different way than existing NMDAR agents. The company's drug development programs based on its GFPA NMDAR modulators include the first-generation molecule, GLYX-13, the second-generation NRX-1050 small molecule series and additional compounds from Naurex's platform of novel NMDAR modulators.
NAUREX
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2008-01-01
Address:
Evanston, Illinois, United States
Country:
United States
Website Url:
http://www.naurex.com
Total Employee:
11+
Status:
Active
Contact:
(847) 871-0377
Email Addresses:
[email protected]
Total Funding:
200.11 M USD
Technology used in webpage:
McAfee SaaS Email
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Investors List
Goudy Park Capital
Goudy Park Capital investment in Series C - Naurex
Sabby Capital
Sabby Capital investment in Series C - Naurex
Adams Street Partners
Adams Street Partners investment in Series C - Naurex
Latterell Venture Partners
Latterell Venture Partners investment in Series C - Naurex
EcoR1 Capital
EcoR1 Capital investment in Series C - Naurex
Cowen Group
Cowen Group investment in Series C - Naurex
Baxter Ventures
Baxter Ventures investment in Series C - Naurex
PathoCapital
PathoCapital investment in Series C - Naurex
Portal Capital
Portal Capital investment in Series C - Naurex
Savitr Capital
Savitr Capital investment in Series C - Naurex
Official Site Inspections
http://www.naurex.com
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
More informations about "Naurex" on Search Engine
NAUREXinternational
NAUREXinternational NAUREXinternational. Never Complacent Ability to provide appropriate and highly qualified manpower Understanding of the market enabling …See details»
Naurex - Crunchbase Company Profile & Funding
Company Type For Profit. Contact Email [email protected]. Phone Number (847) 871-0377. Naurex Inc. is a clinical-stage company developing novel therapies for depression …See details»
About » NAUREXinternational
Founded in 1999 by its current Chairman, NAUREXinternational is today a leading provider of Technical Services and Staffing Solutions in the fields of Oil and Gas (Up, Middle and …See details»
Naurex | LinkedIn
Naurex | 17,424 followers on LinkedIn. Engineering Services | Naurex brings an additional and valuable competence to companies whose priority is the most effective and efficient …See details»
Naurex vets reprise blockbuster NMDA R&D role with $65M …
May 10, 2016 A number of developers--including Johnson & Johnson ($JNJ)--have taken a shot at developing new NMDA drugs, but Naurex distinguished itself with a lead therapy …See details»
Allergan to Acquire Naurex - PR Newswire
Jul 26, 2015 DUBLIN and EVANSTON, Ill., July 26, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN ), a leading global pharmaceutical company, and Naurex Inc., a clinical …See details»
Allergan Successfully Completes Naurex Acquisition
DUBLIN, Aug. 31, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it has successfully completed the …See details»
UPDATED: Allergan bags NMDA depression drugs in $560M …
Jul 26, 2015 Naurex has been working on the NMDA target, a class of therapeutics that has fascinated academics and industry insiders alike for years. Investigators have …See details»
Naurex | LinkedIn
Naurex | 863 followers on LinkedIn. Engineering Services - Oil, Gas, Nuclear, Marine, Renewables, Chemical & Energy | The NAUREX brand has an outstanding and global …See details»
Allergan to acquire Naurex as Teva talks continue | AP News
Jul 26, 2015 Naurex, based in Evanston, Illinois, is privately held. Naurex's drugs are being tested in clinical trials but are not yet approved for sale. The announcement …See details»
Naurex - Funding, Financials, Valuation & Investors - Crunchbase
Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.See details»
VistaGen Is An Interesting Opportunity, Following Allergan's Anti ...
Healthcare. VistaGen Is An Interesting Opportunity, Following Allergan's Anti-Depressant Investment In Naurex. Jul. 29, 2016 9:30 AM ET Vistagen Therapeutics, Inc. (VTGN) …See details»
Naurex - Wikipedia
This page was last edited on 4 March 2017, at 20:29 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may ...See details»
Allergan buys Naurex for $560 million, nabs 2 antidepressants
Jul 27, 2015 Allergan, which agreed to sell its generic drugs business to Israel’s Teva on Monday for $40.5 billion, is continuing its growth-by-specialized-acquisition strategy with …See details»
Naurex - Contacts, Employees, Board Members, Advisors
Naurex is a clinical-stage company developing novel therapeutics for depression and other CNS disorders.See details»
Allergan to Acquire Naurex | Technology Networks
Jul 28, 2015 Allergan plc a leading global pharmaceutical company, and Naurex Inc., a clinical-stage biopharmaceutical company developing transformative therapies for …See details»
Naurex | VentureRadar
Naurex is a clinical-stage biopharmaceutical company developing transformative therapies for challenging disorders of the central nervous system. The company has built a …See details»
Allergan Successfully Completes Naurex Acquisition - PR Newswire
DUBLIN, Aug. 31, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN ), a leading global pharmaceutical company, today announced that it has successfully completed the …See details»
Allergan - Wikipedia
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the …See details»
Joseph Moskal - Founder & Chief Scientific Officer @ Naurex ...
Primary Organization. Naurex. Location Evanston, Illinois, United States. Regions Greater Chicago Area, Great Lakes, Midwestern US. Gender Male. LinkedIn View on LinkedIn. …See details»